Heartflow is a medical technology company advancing the diagnosis and management of coronary artery disease, the #1 cause of death worldwide, using cutting-edge technology. The flagship product—an AI-driven, non-invasive cardiac test supported by the ACC/AHA Chest Pain Guidelines called the Heartflow FFRCT Analysis—provides a color-coded, 3D model of a patient’s coronary arteries indicating the impact blockages have on blood flow to the heart. Heartflow is the first AI-driven non-invasive integrated heart care solution across the CCTA pathway that helps clinicians identify stenoses in the coronary arteries (RoadMap™Analysis), assess coronary blood flow (FFRCT Analysis), and characterize and quantify coronary atherosclerosis (Plaque Analysis). Our pipeline of products is growing and so is our team; join us in helping to revolutionize precision heartcare.
Heartflow is a publicly traded company (HTFL) that has received international recognition for exceptional strides in healthcare innovation, is supported by medical societies around the world, cleared for use in the US, UK, Europe, Japan and Canada, and has been used for more than 400,000 patients worldwide.
The Vice President of Health Economics and Market Access Strategy will lead the development and execution of comprehensive strategies to secure coding, coverage, and payment for Heartflow’s future portfolio of products and services aimed at the early diagnosis of individuals at risk for coronary artery disease. In collaboration with the SVP of Market Access and Reimbursement, this role is responsible for both strategic and operational aspects of market access, including direct engagement with providers, professional societies, government and commercial payers, and other key stakeholders.
Job Responsibilities:
- Develop and execute a comprehensive health economics and market access strategy across HeartFlow’s portfolio, driving cost-effectiveness analyses in collaboration with internal teams and external experts.
- Lead market access initiatives in partnership with the SVP of Market Access & Reimbursement, securing coding, coverage, and payment for future products through engagement with physician specialty societies, CMS, USPSTF, AMA, and other key stakeholders.
- Align market access insights with organizational priorities, ensuring internal and external stakeholders are informed and equipped to support payment advocacy and expansion into new OUS markets.
- Design compelling communication tools that articulate the clinical and economic value of HeartFlow’s technologies, including refined economic models, HTA submissions, and payer-focused clinical dossiers.
- Drive evidence generation strategies with government affairs and clinical teams, shaping materials that strengthen HeartFlow’s value proposition with policymakers and regulatory bodies.
- Engage senior leaders, payers, and providers in both public and private sectors to secure coverage, establish reimbursement pathways, and negotiate payer contracts for Heartflow’s products and services.
- Foster payer partnerships post-coverage to support provider education, explore alternative payment models, and accelerate technology adoption.
- Anticipate market trends and cultivate team capabilities to drive innovative, proactive market access strategies.
- Act as a subject matter expert, educating cross-functional teams—including clinical, sales, marketing, and technology—on reimbursement and market access strategies that align with HeartFlow’s business objectives.
Skills Needed:
- Exceptional communication skills with a proven track record of leading cross-functional teams to achieve successful coding, coverage, and payment for innovative healthcare technologies.
- Deep understanding of reimbursement mechanisms across markets, with specific expertise in at-risk asymptomatic populations.
- Strong leadership and organizational skills with the ability to build and lead a high-performing team composed of internal staff and external consultants.
- Demonstrated success leading the development and presentation of models that quantify the clinical and economic impact of new medical technologies.
- Significant experience in Health Economics & Reimbursement (HE&R) within the medical device sector.
- Proven ability to lead and oversee health economics and outcomes research (HEOR) activities, including budget impact models, cost-effectiveness analyses, real-world evidence generation, and claims database studies.
Educational Requirements & Work Experience:
- Greater than 10 years of demonstrated success in the area of health economics and reimbursement for medical devices, diagnostics, or pharmaceuticals, with strong connections to decision-making individuals and stakeholders in U.S. private and government payer organizations. Prior experience establishing coding, coverage, and payment in at-risk asymptomatic populations.
- Minimum 7 years’ experience building, managing, and leading teams in Market Access, Payer Relations, and Health Economics required. Experience managing teams and consultants in different locations, time zones, and countries is greatly preferred.
- Bachelor’s degree required. Master’s preferred.
This position has an estimated base salary of $250,000 - $320,000, bonus, and equity.
There is a high preference for San Francisco Bay Area candidates, but we will consider remote candidates that are willing to travel up to 50%.
Top Skills
What We Do
Heartflow is the global leader in AI-driven coronary artery disease (CAD) management, transforming how CAD — the world’s leading cause of death — is diagnosed and treated. Our advanced technology generates personalized, precision 3D heart models from a single CT scan, providing clinicians with the clarity and confidence to deliver earlier, more effective treatments — transforming CAD into a disease that can be managed for life.
Heartflow One is the only complete, non-invasive, precision coronary care platform providing patient insights throughout the guideline-directed CCTA pathway. The AI-driven platform — including Roadmap™ Analysis, FFRCT Analysis and Plaque Analysis — is supported by the ACC/AHA Chest Pain Guideline and backed by more than 600 peer-reviewed publications.
With over 400,000 patients treated, more than 1,400 leading institutions adopting our solution, and 99.5% of U.S. lives covered — Heartflow is redefining the standard of coronary care. We're a global company, with employees across the United States, Europe and Japan. Our headquarters are in Mountain View, California, with additional offices in California, Texas, the UK, and Japan.
We believe CAD shouldn’t be a silent threat. By making it screenable, diagnosable, and manageable, we’re changing the story of CAD, empowering clinicians to save lives and giving patients more time for what matters most.
Why Work With Us
Join Us to Rewrite the Story of CAD.
.jpg)
